Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions with unmet medical needs. Co.'s main platform technologies include: semaphorin 4D (SEMA4D) antibody platform, which is the application of its knowledge of SEMA4D biology to develop its main product candidate pepinemab for the treatment of various indications, including cancer and neuroinflammatory and neurodegenerative diseases; and ActivMAb antibody discovery platform, which is a proprietary human antibody discovery platform based on a method for expressing libraries of human monoclonal antibodies on the surface of mammalian pox viruses. We show 23 historical shares outstanding datapoints in our VCNX shares outstanding history coverage, used to compute VCNX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing VCNX market cap history over the course of time is important for investors
interested in comparing VCNX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of VCNX versus a peer is one thing; comparing
VCNX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like VCNX can fluctuate over the course of history.
With this page we aim to empower investors researching VCNX by allowing them to research the VCNX market cap history. |
Free VCNX Email Alerts:
Video: The Importance of Market Cap
